India yesterday granted emergency approval to Bharat Biotech’s Covaxin but faced questions from industry experts and opposition lawmakers after taking the step without publishing efficacy data for the homegrown coronavirus vaccine. The news, announced by the drugs controller general of India (DCGI), was hailed by Prime Minister Narendra Modi and his ministers as a success in the country’s self-reliance push. The government also approved the use of a vaccine developed by AstraZeneca and Oxford University which will be the lead vaccine in India’s immunisation programme. Covaxin was jointly developed with a government institute and means India joins a small list of countries to have approved t
Hence then, the article about govt approval of homegrown vaccine criticised over lack of data was published today ( ) and is available onٌRayaٌ news ( Qatar ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Govt approval of homegrown vaccine criticised over lack of data )